Clinical Trial Update: Erythropoietin Effects After Traumatic Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating erythropoietin effects after traumatic brain injury (Phase 2/Phase 3) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Traumatic Brain Injury | Phase 2, Phase 3 | Status: WITHDRAWN